These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 20051674)

  • 1. Guiding policy decisions for genetic screening: developing a systematic and transparent approach.
    Andermann A; Blancquaert I; Beauchamp S; Costea I
    Public Health Genomics; 2011; 14(1):9-16. PubMed ID: 20051674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic screening: a conceptual framework for programmes and policy-making.
    Andermann A; Blancquaert I; Déry V
    J Health Serv Res Policy; 2010 Apr; 15(2):90-7. PubMed ID: 20176664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.
    Wonodi CB; Privor-Dumm L; Aina M; Pate AM; Reis R; Gadhoke P; Levine OS
    Health Policy Plan; 2012 May; 27 Suppl 2():ii27-38. PubMed ID: 22513730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the theoretical, practical and ethical challenges inherent in prospective health policy analysis.
    Buse K
    Health Policy Plan; 2008 Sep; 23(5):351-60. PubMed ID: 18664524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence-based public health: what does it offer developing countries?
    McMichael C; Waters E; Volmink J
    J Public Health (Oxf); 2005 Jun; 27(2):215-21. PubMed ID: 15820994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors of the innovation, organization, environment, and individual that predict the influence five systematic reviews had on public health decisions.
    Dobbins M; Cockerill R; Barnsley J; Ciliska D
    Int J Technol Assess Health Care; 2001; 17(4):467-78. PubMed ID: 11758291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioethical decision making: an approach to improve the process.
    Holmes C
    Med Care; 1979 Nov; 17(11):1131-8. PubMed ID: 502615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do drug policy makers access research evidence?
    Ritter A
    Int J Drug Policy; 2009 Jan; 20(1):70-5. PubMed ID: 18226519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five propositions for improving decision making about the environment in developing communities: insights from the decision sciences.
    Kellon D; Arvai J
    J Environ Manage; 2011 Mar; 92(3):363-71. PubMed ID: 21035941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking evidence from health technology assessments to policy and decision making: the Alberta model.
    Borowski HZ; Brehaut J; Hailey D
    Int J Technol Assess Health Care; 2007; 23(2):155-61. PubMed ID: 17493300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of context on evidence utilization: a framework for expert groups developing health policy recommendations.
    Dobrow MJ; Goel V; Lemieux-Charles L; Black NA
    Soc Sci Med; 2006 Oct; 63(7):1811-24. PubMed ID: 16764980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical research strategy to support shared decision making.
    Tunis SR
    Health Aff (Millwood); 2005; 24(1):180-4. PubMed ID: 15647229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond evidence--to ethics: a decision-making framework for health promotion, public health and health improvement.
    Tannahill A
    Health Promot Int; 2008 Dec; 23(4):380-90. PubMed ID: 18971394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development and dilemmas of health impact assessment].
    Cianciara D; Wysocki MJ
    Przegl Epidemiol; 2008; 62(3):623-32. PubMed ID: 19108527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Policy issues related to expanded newborn screening: a review of three genetic/metabolic disorders.
    Bishop Hubbard H
    Policy Polit Nurs Pract; 2007 Aug; 8(3):201-9. PubMed ID: 18178927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening tool development for health impact assessment of large administrative structural changes.
    Ravn AK; Nicolaisen H; Linnrose K; Folkersen MW; Kraemer SR; Gulis G
    Scand J Public Health; 2008 Nov; 36(8):789-94. PubMed ID: 18684781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A development framework for promoting evidence-based policy action: drawing on experiences in Sri Lanka.
    Hornby P; Perera HS
    Int J Health Plann Manage; 2002; 17(2):165-83. PubMed ID: 12126211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions.
    Wilfond BS; Parad RB; Fost N
    J Pediatr; 2005 Sep; 147(3 Suppl):S109-13. PubMed ID: 16202773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based medical approach to clinical medicine and health policy-making in the 21st century].
    Li YP; Tao TJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):548-9. PubMed ID: 12905676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.